JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Activity Details


580 * Wed, 8/3/2011, 2:00 PM - 3:50 PM CC-D237
Sample Size in Clinical Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Eric Yaw Frimpong, U.S. Food and Drug Administration
2:05 PM Optimal Sample Size and Go/No-Go Decision Based on Probability of Success Kaihong Jiang, sanofi-aventis
2:20 PM R Functions for Sample Size and Probability Calculations for Assessing Consistency of Treatment Effects in Multi-Regional Clinical Trials Mingyu Li, Celgene Corporation ; Hui Quan, sanofi-aventis ; Joshua Chen, Merck & Co., Inc. ; Yoko Tanaka, Eli Lilly and Company ; Peter Ouyang, Celgene Corporation ; Xiaolong Luo, Celgene Corporation ; Gang Li, Johnson & Johnson Pharmaceutical R&D, LLC
2:35 PM One-Sample Proportion Testing Procedures for Hypothesis of Inequality — Wayne Zhong, Octagon Research Solutions, Inc. ; Bob Zhong, Johnson & Johnson Pharmaceutical R&D, LLC
2:50 PM Sample Size Determination for Cut Point of Immunogenicity Assays — Lanju Zhang, MedImmune, Inc. ; Jianchun Zhang, MedImmune, Inc. ; Harry Yang, MedImmune, Inc.
3:05 PM Power Calculation in Clinical Trials Lingling Han, Merck & Co., Inc.
3:35 PM Floor Discussion



2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.